DIRECTOR'S DEALS: David Newlands, 69, Chairman, Imperial Innovations

The fund owns around 9 per cent of Circassia Pharmaceuticals,but Circassia’s shares plummeted 67 per cent on Monday after it halted trials when the medication failed to outperform a placebo.